Navigation Links
West to Co-present Research Findings on Understanding the Patient Journey through the Phases of a Chronic Disease
Date:11/1/2013

EXTON, Pa., Nov. 1, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed primary user research with its partner, Insight Product Development, aimed at understanding the needs of patients, caregivers and clinicians in the field of injectable therapies for chronic diseases. West will co-present a poster summarizing the findings at the Parenteral Drug Association (PDA) conference on "The Universe of Prefilled Syringes and Injection Devices" in Basel, Switzerland November 5-6.

Chris Evans, Director of Innovation at West, and Craig Scherer, Senior Partner of Insight, will present at 10:45 a.m. on November 5 and during session breaks throughout both days of the conference.

With the increase in chronic conditions such as diabetes and autoimmune diseases (such as rheumatoid arthritis and multiple sclerosis) it is becoming more critical to provide safe and effective drug delivery systems that can be used by the patient for self-administration in the home environment. West provides a number of solutions to support the packaging and delivery of these conditions, and realizes the importance of ensuring a deep understanding of patients' needs. This is essential to ensure that systems are provided that optimize patient experience and improve outcomes through the patient's journey from initial diagnosis to a point of being in control of their treatment.

"Effective drug delivery is no longer just about the drug molecule," said Graham Reynolds, Vice President of Marketing and Innovation at West. "We recognize that a medicine can be truly effective only if it is contained and delivered safely, and if the patient maintains adherence to the required regimen. This can be achieved by providing a delivery system that enables effective delivery, and is designed with a recognition and understanding of the patient's emotional and physical state at various stages of the journey."

West has a seven-year relationship with Insight Product Development, a healthcare-centric product development consultancy. "Being able to identify and frame the needs of the users as they relate to their delivery device is critical for pharmaceutical companies to support the patient beyond the drug," said Craig Scherer, Senior Partner of Insight. "This process is critical to innovating differentiated devices that help drive adoption and adherence, resulting in better outcomes for the patient and greater success for pharmaceutical companies."

The paper to be presented at the PDA conference will highlight the transition from initial diagnosis, often creating a feeling of denial and depression. In this stage of the journey, the patient may make comments such as, "All of a sudden it's there, and you didn't want it or plan for it." As the journey progresses, the patient may feel in control of the treatment, and make comments such as, "It's a marathon not a sprint" and "I'm always working on being better." West will use the study results to work with its pharmaceutical partners to help improve patient outcomes.

About West (www.westpharma.com)
West works side-by-side with its healthcare partners from concept to the patient, designing and manufacturing packaging, diagnostic and delivery systems that promote the efficiency, reliability and safety of their products. Every day, West is leading the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched and growing knowledge base of relevant pharmaceutical product testing, development and packaging. Based in Exton, Pa., West supports its customers from sales, manufacturing, customer support and research and development locations in North and South America, Europe, Asia and Australia. Established in 1923, West's 2012 sales were $1.3 billion.

About Insight Product Development (www.insightpd.com)
With 350 completed healthcare programs and over 30,000 hours of research completed worldwide, Insight provides design and innovation to clients on global scale. Since 1988, Insight has relied on its research, design and engineering teams to create device solutions that are user-centered, safe and reliable.

West and the diamond logo and By your side for a healthier world™ are registered trademarks or trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.

Media Contact
Kristin Villiotte
Schwartz MSL
781-684-0770
westpharma@schwartzmsl.com


'/>"/>
SOURCE West Pharmaceutical Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. IBM Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery
2. Research by ClinMet Scientific Founder and Colleagues Point to Enzyme that Restores Function in Diabetic Kidney Disease
3. PRA Staff Named Finalists in Clinical Researcher of the Year Competition
4. McCord Research Appoints Wound Care Education Expert
5. Neurology Devices Market is Expected to Reach USD 13.6 Billion Globally in 2019: Transparency Market Research
6. Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research
7. Philanthropic Grants, Product Launches, Promising Partnerships, and Customer Satisfaction Rankings - Research Report on CVS Caremark, Walgreens, McKesson, AmerisourceBergen, and Cardinal Health
8. Life Technologies Awards Digital PCR Innovation Grants to Five Research Labs
9. Kaiser Permanente Researchers Honored for Drug Therapy Study
10. InCube Labs Enters into an Agreement with the Engineering Research Center for Revolutionizing Metallic Biomaterials
11. Healthcare Sector Announced Clinical Data Presentation, Upcoming Financial Release Schedules and Updates on New Drug Applications - Research Report on Alexion, Pacira, pSivida, Momenta and Impax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
Breaking Medicine Technology:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):